Finding the tumor copycat: Therapy fails, patients don't
- 1 September 2010
- journal article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 16 (9), 974-975
- https://doi.org/10.1038/nm0910-974
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- AACR Centennial Series: The Biology of Cancer Metastasis: Historical PerspectiveCancer Research, 2010
- Colorectal cancerThe Lancet, 2010
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033Journal of Clinical Oncology, 2008
- Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 StudyJournal of Clinical Oncology, 2007
- Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer MetastasisEndocrine Reviews, 2007
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- EGFRMutation and Resistance of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003